Despite the vast improvements of cell therapy in spinal cord injury treatment, no optimum
protocol has been developed for application of neural stem/progenitor cells. In this regard …

Spinal cord injury (SCI) can lead to severe motor, sensory and social impairments having a
huge impact on patients' lives. The complex and time-dependent SCI pathophysiology has …

Abstract Introduction Neural stem cells (NSCs) have demonstrated multimodal therapeutic
function for stroke, which is the leading cause of long‐term disability and the second leading …

Spinal cord injury (SCI) often causes loss of sensory and motor function resulting in a
significant reduction in quality of life for patients. Currently, no therapies are available that …

Three different sources of human stem cells—bone marrow-derived mesenchymal stem
cells (BM-MSCs), neural progenitors (NPs) derived from immortalized spinal fetal cell line …

The management of facial defects has rapidly changed in the last decade. Functional and
esthetic requirements have steadily increased along with the refinements of surgery. In the …

Human mesenchymal stem cells derived from Wharton's jelly (WJ-MSCs) were used for the
treatment of the ischemic-compression model of spinal cord injury in rats. To assess the …

Neural stem/progenitor cells (NSPCs) have a potential to treat various neurological
diseases, such as Parkinson's Disease, Alzheimer's Disease, and Spinal Cord Injury …

Spinal cord injury (SCI) is associated with substantial healthcare challenges, frequently
resulting in enduring sensory and motor deficits alongside various chronic complications …

Background We previously reported that functional recovery of rats with spinal cord
contusions can occur after acute transplantation of neural stem cells distal to the site of …